Innovative Healthcare Market Research Companies to Watch in 2025

 

The healthcare industry is undergoing unprecedented transformation. Technological advancements, regulatory shifts, rising patient-centric care models, and the acceleration of precision medicine are reshaping the global healthcare landscape. In this rapidly evolving ecosystem, healthcare market research companies play a pivotal role by providing strategic insights, forecasting trends, and guiding decision-making for pharmaceutical companies, biotech firms, medical device manufacturers, and investors.

As the demand for accurate and actionable data intensifies, certain market research firms are emerging as leaders in innovation, offering integrated analytics, real-world evidence, and disease-specific intelligence. The following article highlights the innovative healthcare market research companies to watch in 2025, showcasing their capabilities, expertise, and unique value propositions.

IQVIA

IQVIA continues to stand at the forefront of healthcare analytics and market intelligence. Leveraging a vast repository of real-world data spanning over one billion patient records globally, IQVIA provides comprehensive insights into therapeutic markets, patient pathways, and competitive landscapes. The company integrates primary and secondary research methodologies with advanced AI-driven analytics to deliver precision insights tailored for pharmaceutical and biotech clients.

IQVIA’s solutions cover clinical trial analytics, epidemiological modeling, patient segmentation, and market access studies. Their ability to combine real-world evidence with predictive analytics enables clients to anticipate market trends, optimize commercialization strategies, and assess therapeutic performance. With a strong presence across North America, Europe, and emerging markets, IQVIA is uniquely positioned to guide global healthcare stakeholders in making data-driven decisions.

Frost & Sullivan

Frost & Sullivan has a long-standing reputation as a trusted strategic growth consultancy, offering deep insights into healthcare innovation and market dynamics. Its research services span pharmaceuticals, medical devices, diagnostics, and digital health. The firm emphasizes growth opportunity analysis, competitive benchmarking, and technology trend evaluation, helping organizations identify disruptive innovations and new market segments.

Their healthcare-focused studies frequently explore emerging technologies, including AI-assisted diagnostics, telemedicine adoption, and remote patient monitoring. By combining sector-specific intelligence with macroeconomic analysis, Frost & Sullivan provides actionable strategies that align with organizational objectives. For healthcare executives and investors, the firm’s research supports portfolio planning, market entry assessments, and long-term forecasting.

GlobalData Healthcare

GlobalData Healthcare is renowned for its in-depth industry analysis and therapeutic intelligence across multiple healthcare domains. Its proprietary platforms deliver comprehensive data on pipelines, regulatory updates, market sizing, and competitive landscapes. With specialized reports covering oncology, cardiovascular diseases, rare diseases, and digital therapeutics, GlobalData enables pharma and biotech companies to evaluate growth potential, unmet medical needs, and investment opportunities.

The company’s research is enriched by analyst-driven insights, which combine quantitative forecasts with qualitative market understanding. GlobalData’s expertise in emerging markets and established regions alike allows clients to make informed decisions about market expansion, partnerships, and clinical trial planning.

DelveInsight

DelveInsight is emerging as one of the most innovative healthcare market research firms globally, with a particular focus on therapeutic intelligence and disease-specific analysis. Known for its rigor in primary and secondary research, DelveInsight provides actionable insights across pharmaceuticals, biotechnology, and medical devices. Its expertise spans over 7,000 indications and 27,000 pipeline drugs, offering a holistic view of market opportunities and clinical developments.

The firm’s offerings include epidemiology forecasting, drug market analysis, competitive intelligence, and commercialization planning. DelveInsight’s ability to integrate clinical, regulatory, and market data helps pharma and biotech companies prioritize R&D investments, assess pipeline performance, and develop launch strategies. Their disease-specific insights, combined with global market intelligence, make DelveInsight a trusted partner for investors and executives seeking precision guidance in high-growth therapeutic areas.

MarketsandMarkets

MarketsandMarkets is one of the fastest-growing B2B market research and consulting firms, known for its deep analytical capabilities across healthcare and life sciences. The firm provides actionable insights on biopharma, digital health, diagnostics, and healthcare IT, covering over 30,000 high-growth niche markets.

Leveraging its proprietary KnowledgeStore platform, MarketsandMarkets integrates AI-based analytics with expert human insights to forecast trends, assess competitive positioning, and identify revenue opportunities. Its research helps pharmaceutical companies and investors navigate complex regulatory environments, plan market entry strategies, and evaluate emerging technologies, such as next-generation biologics, wearable medical devices, and AI-assisted treatment platforms.

The Business Research Company (TBRC)

TBRC offers comprehensive healthcare market research solutions, with a strong emphasis on data-driven decision-making and global coverage. Their research includes market sizing, epidemiology, competitive benchmarking, and strategic insights across pharmaceuticals, medical devices, and healthcare services.

In addition to syndicated reports, TBRC delivers tailored analytics for specific therapeutic areas, including oncology, cardiovascular, neurology, and rare diseases. By integrating regional insights with global trends, the firm supports market entry strategies, investment decisions, and competitive intelligence. TBRC’s extensive network and methodology make it a reliable partner for companies seeking to optimize growth in complex and evolving healthcare markets.

IQVIA CORE™ and Digital Solutions

IQVIA’s digital solutions, including the CORE™ platform and Orchestrated Customer Engagement (OCE), exemplify innovation in healthcare market research. These platforms enable clients to integrate real-world evidence, clinical trial data, and patient-reported outcomes to optimize commercialization, patient engagement, and market access strategies. The adoption of digital technologies for analytics, visualization, and predictive modeling allows IQVIA to deliver unparalleled granularity and strategic insights.

GlobalData Patient and Market Insights

GlobalData has also expanded its focus on patient-centric research, offering insights into patient behavior, treatment adoption, and therapy compliance. By combining qualitative interviews with quantitative modeling, the firm provides a detailed understanding of treatment dynamics, unmet medical needs, and regional healthcare variations. This approach enables pharma companies and healthcare investors to design more effective market strategies and prioritize investments in high-growth therapeutic segments.

Mordor Intelligence

Mordor Intelligence is another notable firm to watch in 2025, providing accessible, data-driven research across pharmaceuticals, medical devices, and healthcare services. Its cardiovascular, oncology, and digital therapeutics market reports combine qualitative analysis with quantitative forecasting, offering actionable insights on market potential, competitive strategies, and emerging trends. For both established players and new entrants, Mordor Intelligence facilitates strategic decision-making and investment planning in fast-growing healthcare sectors.

BIS Research

BIS Research specializes in innovation-driven segments, such as regenerative medicine, AI-assisted diagnostics, minimally invasive devices, and next-generation biologics. Their research integrates technology assessment, market segmentation, and competitive intelligence to identify opportunities for growth and commercialization. By highlighting technology convergence and emerging therapies, BIS Research helps healthcare stakeholders anticipate market shifts and develop forward-looking strategies.

Grand View Research

Grand View Research offers comprehensive data analytics and market forecasting solutions, covering pharmaceuticals, medical devices, and healthcare IT. Their cardiovascular, oncology, and rare disease research focuses on product innovation, clinical trial outcomes, and regulatory developments. By combining financial, operational, and clinical data, Grand View Research provides a holistic view of market dynamics and growth opportunities, enabling healthcare executives to make informed strategic decisions.

Key Trends Driving Healthcare Market Research in 2025

Several trends are shaping the healthcare market research landscape in 2025:

• Precision Medicine and Targeted Therapies: Research firms increasingly provide insights into genetic, biomarker-driven, and personalized therapeutic approaches.
  
  

• Real-World Evidence Integration: Leveraging EHRs, claims data, and patient registries for actionable intelligence.
  
  

• Digital Health and AI: Adoption of AI-powered analytics, telemedicine insights, wearable devices, and digital therapeutics is reshaping research methodologies.
  
  

• Patient-Centric Analytics: Greater focus on patient behavior, adherence, and treatment satisfaction to guide market strategy.
  
  

• Regulatory and Market Access Expertise: Navigating evolving FDA, EMA, and HTA requirements is critical for commercialization and global expansion.

Conclusion

The healthcare market in 2025 is increasingly complex, requiring precision, expertise, and timely insights. Companies like IQVIA, Frost & Sullivan, GlobalData Healthcare, and DelveInsight are setting the benchmark in delivering integrated, data-driven, and disease-specific intelligence. Investors, pharmaceutical executives, and medical device leaders can leverage these firms to identify emerging trends, evaluate market opportunities, and optimize strategic planning. As the industry embraces digital health, real-world evidence, and patient-centric innovation, partnering with forward-looking healthcare market research companies will be crucial for achieving competitive advantage and sustainable growth.